Hepatocellular transport proteins and their role in liver disease

World Journal of Gastroenterology

Volumn 7, Issue 2, 2001, Pages 157-169

  Stanca, C ^a   Jung, D ^a   Meier, P J ^a   Kullak Ublick, G A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; BILE SALT; CARRIER PROTEIN; CATION; COPPER; PHOSPHOLIPID; SODIUM ION;

CELL TRANSPORT; CHOLESTASIS; DRUG INDUCED DISEASE; DUBIN JOHNSON SYNDROME; EXCRETION; FAMILIAL DISEASE; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CELL; LIVER DISEASE; PATHOGENESIS; PHOSPHATE EXCRETION; PHYSIOLOGY; PREGNANCY DISORDER; REVIEW; SALT INTAKE; SEPSIS; WILSON DISEASE;

EID: 0035040204     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i2.157     Document Type: Review

References (188)

1. Uptake of bile acids by perfused rat liver
2. Bile acids
3. Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport
4. Hepatocellular transport of bile acids
5. The secretory function of the liver: New aspects of hepatobiliary transport
6. + on bile acid uptake by isolated rat hepatocytes: Evidence for a heterogeneous system
7. Transport of sodium, chloride and taurocholate by cultured rat hepatocytes
8. Different relationships between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions
9. Identification and characterization of a basolateral dicarboxylate-cholate antiport system in rat hepatocytes
10. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes
11. Cholate uptake in basolateral rat liver plasma membrane vesicles and in liposomes
12. Bile secretion and the enterohepatic circulation of bile acids
13. +/bile acid contransport system
14. +/bile acid cotransporter
15. Molecular cloning and functional characterization of two alternatively spliced Ntcp isoforms from mouse liver
16. +/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters
17. In situ localization of the hepatocytic Na+/taurocholate cotransporting polypeptide in rat liver
18. +-bile acid cotransporter using peptide and fusion protein antibodies
19. + bile acid cotransport system in COS-7 cells
20. +-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells
21. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
22. Expression cloning and characterization of the hamster ileal sodium - Dependent bile acid transporter
23. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter
24. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties
25. +/bile acid cotransporter in extrahepatic cholestasis
26. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
27. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion
28. Regulation of hepatocyte bile salt transporters during hepatic regeneration
29. +-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes
30. Phylogenic and ontogenic expression of hepatocellular bile acid transport
31. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells
32. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation
33. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis
34. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters
35. Hepatic basolateral sodium-dependent bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia
36. +-independent organic anion transporter
37. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
38. Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver
39. Immunologic distribution of an organic anion transport protein in rat liver and kidney
40. Polyspecific substrate uptake by the hepatic organic anion transporter Oatpl in stably transfected CHO cells
41. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver
42. The choroid plexus epithelium is the site of the organic anion transport protein in the brain
43. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain
44. The transport of bile acids in liver cells
45. Hepatic transport of bile salts
46. Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells
47. 3 exchange
48. Identification of glutathione as a driving force and leukotriene C4 as a substrate for Oatp1, the hepatic sinusoidal organic solute transporter
49. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2
50. +-independent organic anion transporting polypeptide (oatp) in rat liver and kidney
51. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2)
52. Dose-related effects of phenobarbital on hepatic microsomal enzymes
53. Effects of phenobarbital on the plasma disappearance and biliary excretion of drugs in rats
54. 3H-digitoxin: Modification by bile salts and phenobarbital
55. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides
56. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats
57. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats
58. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver
59. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1
60. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
61. A novel human hepatic organic anion transporting polypeptide (OATP2)
62. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
63. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide
64. Organic anion transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
65. Hepatic uptake of cholecystokinin octapeptide (CCK-8) by organic anion transporting polypeptides Oatp4 and OATP8 of rat and human liver
66. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
67. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier
68. Multispecific amphipathic substrate transport by an organic anion transporter of human liver
69. Dehydroepiandrosterone sulfate (DHEAS): Identification of a carrier protein in human liver and brain
70. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents
71. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
72. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations
73. The multispecific organic anion transporter (OAT) family
74. Organic cation transporters in intestine, kidney, liver, and brain
75. Molecular pharmacology of organic cation transporters in kidney
76. Expression cloning and characterization of a novel multispecific organic anion transporter
77. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney
78. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
79. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain
80. Drug excretion mediated by a new prototype of polyspecific transporter
81. Cloning and characterization of two human polyspecific organic cation transporters
82. Cloning and functional expression of a human liver organic cation transporter
83. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
84. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump
85. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells
86. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
87. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
88. MRP3, an organic anion transporter able to transport anti-cancer drugs
89. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (mrp3)
90. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells
91. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats
92. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
93. Transport function and hepatocellular localization of mrp6 in rat liver
94. Mutations in ABCC6 cause pseudoxanthoma elasticum
95. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system
96. ATP-dependent bile salt transport in canalicular rat liver plasma-membrane vesicles
97. ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt
98. Bile acid transport across the hepatocyte canalicular membrane
99. Identification of a sister gene to P-glycoprotein
100. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
101. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/ P-glycoprotein
102. Molecular cloning and characterization of the murine bile salt export pump
103. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
104. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice
105. High-resolution maps of the murine chromosome 2 region containing the cholesterol gallstone locus, Lith1
106. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/ J strains of mice
107. Genetic mapping of hepatocanalicular transporters establishes sister-P-glycoprotein (spgp) as a candidate for the major gallstone gene (Lith1)
108. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: Physical-chemistry of gallbladder bile
109. Phenotypic characterization of ATP-dependent canalicular bile salt transport in C57L/J and AKR/J mice
110. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
111. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man
112. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
113. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
114. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein
115. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
116. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver
117. Canalicular multispecific organic anion transporter/ multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
118. Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes
119. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport
120. Evidence for the presence of a phosphatidylcholine translocator in isolated rat liver canalicular plasma membrane vesicles
121. Expression of a rat liver phosphatidylcholine translocator in Xenopus laevis oocytes
122. Evidence for an ATP-independent long-chain phosphatidylcholine translocator in hepatocyte membranes
123. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
124. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
125. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
126. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
127. Wilson's disease
128. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene
129. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
130. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease
131. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae
132. Localization of the Wilson's disease protein product to mitochondria
133. Localization of the Wilson's disease protein in human liver
134. Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes
135. hCTR1: A human gene for copper uptake identified by complementation in yeast
136. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion
137. Orthotopic liver transplantation for Byler disease
138. Clinical and biochemical findings in progressive familial intrahepatic cholestasis
139. Genetic basis of progressive familial intrahepatic cholestasis
140. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21q22, the benign recurrent intrahepatic cholestasis region
141. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
142. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24
143. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
144. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
145. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse
146. Benign recurrent intrahepatic cholestasis: Altered bile acid metabolism
147. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II / Dubin-Johnson syndrome
148. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
149. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
150. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome
151. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation
152. Bile acids: The good, the bad, and the ugly
153. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
154. The rat canalicular conjugate export pump (mrp2) is down-regulated in intrahepatic and obstructive cholestasis
155. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes
156. Identification of a nuclear receptor for bile acids
157. Bile acids: Natural ligands for an orphan nuclear receptor
158. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
159. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription
160. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
161. Don't know much bile-ology
162. Decreased bilirubin transport in the perfused liver of endotoxemic rats
163. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
164. Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation
165. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes
166. +/taurocholate contransporter (NTCP)
167. 3 excretion and blocks the choleretic effect of nitric oxide in rat liver
168. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease
169. Exploring the genetic role of the HLA-DPBI locus in Chileans with intrahepatic cholestasis of pregnancy
170. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy
171. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
172. Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
173. Biliary excretion of estradiol-17 beta-glucuronide in the rat
174. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate
175. Mrp2 is essential for estradiol-17beta (beta-D-glucuronide)-induced cholestasis in rats
176. The effects of liver transplantation and cyclosporine on bile formation and lipid composition: An experimental study in the rat
177. Rifampicin-induced elevation of serum bile acids in man
178. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2
179. Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats
180. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene
181. Downregulation of the hepatocellular organic anion transporters OATP-C and MRP2 in patients with primary sclerosing cholangitis
182. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver
183. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
184. Inhibition of bile flow, hepatobiliary exocytosis, and mrp2-insertion into the canalicular membrane by taurolithocholic acid is reversed by tauroursodeoxycholic acid in the perfused rat liver
185. Functional, biochemical, and morphological hepatobiliary effects in rats chronically exposed to a steroidal antiandrogen
186. Danazol-induced cholestasis
187. Expression of the hepatocyte canalicular multidrug resistance associated protein 2 (MRP2) in primary biliary cirrhosis
188. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis